This inventor holds 4 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: Korea Research Institute of Bioscience and Biotechnology, National Cancer Center, National Institute of Health and Medical Research. Active years: 2012-2017.
Company Filing History:




Years Active: 2012-2017
Title: Yoonkyung Kim: Innovator in Tumor Diagnostics
Introduction
Yoonkyung Kim is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of tumor diagnostics, holding a total of 4 patents. His innovative work focuses on improving the efficiency of diagnostic methods for tumors, showcasing his expertise in bioscience and biotechnology.
Latest Patents
Yoonkyung Kim's latest patents include a method to enhance the tumor diagnostic efficiency of multivalent ligands. This method involves regulating the stoichiometric ratio between inner surface functionalities and ligand moieties for effective tumor targeting. Additionally, he has developed iodine-containing radial-shaped macromolecular compounds, which serve as active ingredients in computed tomography (CT) contrast media. This invention significantly improves the duration of contrast enhancement compared to existing small molecular contrast media compounds containing iodine.
Career Highlights
Throughout his career, Yoonkyung Kim has worked with esteemed organizations such as the Korea Research Institute of Bioscience and Biotechnology and the National Cancer Center. His work in these institutions has allowed him to advance his research and contribute to the development of innovative diagnostic methods.
Collaborations
Yoonkyung Kim has collaborated with notable colleagues, including Hye-Youn Jung and June-Key Chung. These partnerships have fostered a collaborative environment that enhances the research and development of new technologies in the field.
Conclusion
Yoonkyung Kim's contributions to tumor diagnostics through his innovative patents and collaborations highlight his role as a leading inventor in the bioscience sector. His work continues to pave the way for advancements in medical diagnostics.